Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Explore the primary drivers of risk in Dividend Aristocrats ETF, including sector shifts and interest-rate impacts, with practical mitigation tips.
26,217 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Trump unveils a plan to monetize passage through the Strait of Hormuz, triggering market moves and raising questions ...
Kalshi unveils a new prediction market to price future GPU computing power, positioning compute oil as a key asset cl...
Tesla's robotaxi just launched in Miami, marking a milestone for autonomous transport. Yet the pilot comes with a del...
Investor interest is shifting from famous names to durable space economy players. This article breaks down why predic...
Jaguar Land Rover is recalling roughly 2,300 US-registered I-Pace electric SUVs due to a high-voltage battery fire ri...
Crypto executives and bank regulators left Washington with a shared sense that the work is far from over. The third W...
Vitalik Buterin has resumed selling ETH, logging new multi-million transfers as ether struggles to stay above the $2,...
A clear, practical look at Bowhead Specialty's Q4 2025 earnings transcript. Learn what the numbers mean, which metric...
Bitcoin and Ethereum lead a broad crypto rebound as on-chain data shows heavy whale buying. XRP and major altcoins ra...
MercadoLibre's 2025 earnings reveal how a Latin American e-commerce and fintech leader is balancing growth with profi...
Investors chasing quantum headlines often overlook how a big subscription software player can deliver durable AI-and-...